Brexpiprazole versus placebo or other antidepressive agents for treating depression

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute- and long-term treatment of major depression.

This is a protocol.